Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Thrombosis and Fibrinolysis Markers in Patients Undergoing Aortic Valve Replacement Predict Outcome

NCT04234841 is registered in ClinicalTrials.gov with East and North Hertfordshire NHS Trust as lead sponsor.

NCT NCT04234841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04234841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Thrombosis and Fibrinolysis Markers in Patients Undergoing Aortic Valve Replacement Predict Outcome
Lead sponsor
East and North Hertfordshire NHS Trust
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2020
Completion date
January 31, 2028
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis